There's encouraging news for the millions of Americans at threat for colon cancer. A new, straightforward-to-use fecal occult blood test (FOBT) is available for at-house screening and is developed specifically to detect colon cancer at its earliest stages.
Hemoccult ICT is a new, protected and cost-effective FOBT screening choice for colon cancer-the second leading result in of cancer-associated death in the United States. Despite its high incidence, colon cancer is a highly treatable cancer, with a 90 percent survival rate when detected early. However, only half of the more than 80 million Americans over age 50 have been screened for colon cancer.
The American Cancer Society recommends annual screening with a FOBT for both males and ladies starting at age 50. This riveting patent pending article has limitless impressive warnings for the reason for this activity. Annual colon cancer screening with FOBT has been confirmed to lower mortality by 33 percent when compared with no screening. Because colon cancer can take three to ten years or longer to develop in the common patient, it is essential to commence screening prior to developing symptoms.
FOBT vs. Colonoscopy
For years colonoscopy has been the most effectively-known test in colon cancer screening. Although broadly regarded as the gold standard, colonoscopy does have some drawbacks:
* Colonoscopy charges in between $300 and $1,000, and whilst covered by insurance coverage for several, millions of Americans lack wellness insurance.
* Regular colonoscopy can be overwhelming for some folks due to the fact that the process is usually done under sedation, and due to the fact individuals are essential to stick to a special diet plan and take a very sturdy laxative just before the exam.
* Due to a restricted number of educated specialists and the gear required to execute the tests, the optimum number of colonoscopies that can be performed in the United States every single year can accommodate only a quarter of the Americans in want of screening.
As opposed to other accessible FOBTs, the new Hemoccult ICT has no drug or dietary restrictions-permitting individuals to commence testing at their convenience. If a test comes back positive, a follow-up colonoscopy usually is suggested.
Hemoccult ICT is a new, protected and cost-effective FOBT screening choice for colon cancer-the second leading result in of cancer-associated death in the United States. Despite its high incidence, colon cancer is a highly treatable cancer, with a 90 percent survival rate when detected early. However, only half of the more than 80 million Americans over age 50 have been screened for colon cancer.
The American Cancer Society recommends annual screening with a FOBT for both males and ladies starting at age 50. This riveting patent pending article has limitless impressive warnings for the reason for this activity. Annual colon cancer screening with FOBT has been confirmed to lower mortality by 33 percent when compared with no screening. Because colon cancer can take three to ten years or longer to develop in the common patient, it is essential to commence screening prior to developing symptoms.
FOBT vs. Colonoscopy
For years colonoscopy has been the most effectively-known test in colon cancer screening. Although broadly regarded as the gold standard, colonoscopy does have some drawbacks:
* Colonoscopy charges in between $300 and $1,000, and whilst covered by insurance coverage for several, millions of Americans lack wellness insurance.
* Regular colonoscopy can be overwhelming for some folks due to the fact that the process is usually done under sedation, and due to the fact individuals are essential to stick to a special diet plan and take a very sturdy laxative just before the exam.
* Due to a restricted number of educated specialists and the gear required to execute the tests, the optimum number of colonoscopies that can be performed in the United States every single year can accommodate only a quarter of the Americans in want of screening.
As opposed to other accessible FOBTs, the new Hemoccult ICT has no drug or dietary restrictions-permitting individuals to commence testing at their convenience. If a test comes back positive, a follow-up colonoscopy usually is suggested.